MN SF 3271
died on adjournmentIndependent audits of 340B entity reporting by nonprofit public interest organizations authorization; revenue from prescription drugs obtained under the 340B program to be used for charity care; enforcement by the attorney general authorization
Minnesota · 2025-2026 · upper
Quick answers
Did MN SF 3271 pass?
No. MN SF 3271 died when the 2025-2026 session adjourned without final action on it. Bills that die this way are sometimes reintroduced in a later session. Latest recorded action (2025-04-03): Referred to Health and Human Services
What is MN SF 3271 about?
MN SF 3271 is a bill in the 2025-2026 titled “Independent audits of 340B entity reporting by nonprofit public interest organizations authorization; revenue from prescription drugs obtained under the 340B program to be used for charity care; enforcement by the attorney general authorization”.
Who sponsors MN SF 3271?
Abeler is the primary sponsor of MN SF 3271.
- Introduced
- 2025-04-03
- Latest action
- 2025-04-03 — Referred to Health and Human Services
- Bill type
- bill
- Last updated
- —
Subjects
Sponsors
- Abelerprimary
Committees
Not provided by source.
Action timeline
2025-04-03
Introduction and first reading
introduction
2025-04-03
Referred to Health and Human Services
referral-committee
Versions
- Introduction — 2025-04-02Compare
Documents
Votes
Not provided by source.
Related bills
No related bills recorded for this bill.
Official source
Attribution
Data from openstates_bulk_csv, retrieved 2026-07-24T05:24:48.331508Z
Inspect retained evidence for changes recorded after evidence tracking began:
Session-wide evidence can include changes to other bills:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=MN&identifier=SF 3271. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
See the methodology page for data sources and limitations.